Page 173 - ASHG 2012 Annual Meeting Program Guide

162
POSTER SESSIONS
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
genes.
F. Cherbal, R. Bakour, S. Adane, K. Boualga, N.
Salhi, A. Chikh, P. Maillet.
1269
W GENECAPP: Sequence-specific in vivo analysis
of protein-DNA interactions in human cancer cell
lines.
H. Guillen Ahlers, A. Ludwig-Kubinski, S. Tian,
C. Anderson, A. M. Greene, J. Kennedy-Darling, M.
Levenstein, R. Knoener, M. Chesnik, M. Scalf, Y. Yuan, R.
Cole, M. Shortreed, L. Cirillo, R. Stewart, L. M. Smith, M.
Olivier.
1270
T Examination of UVR-induced DNA damage and
repair and its association with apoptosis in human
keratinocytes and fibroblasts.
M. Karbaschi, M. D.
Evans, S. Macip, M. S. Cooke.
1271
F The
IRS1
rs2943641 genetic variant and the
protection against cancer.
S. Romeo, C. Maglio, J.
Andersson Assarsson, K. Sjöholm, L. Sjöström, L. M.
Carlsson.
1272
W Lynch syndrome: Awareness among medical
students at a United States medical school.
J. S. Taylor,
M. K. Frey, M. Biewald, M. Worley, Jr., S. Lin, K. Holcomb.
1273
T Characterization of active chromatin signatures
in testicular germ cell tumor cell lines.
S. J. White,
Y. van de Zwan, C. M. de Boer, F. Rossello, L. H. J.
Looijenga, A. J. Notini.
1274
F Single nucleotide polymorphisms and cancer
risk in individuals with Costello syndrome.
B. A.
Thompson, G. Desachy, J. Quinn, A. E. Toland, L. A.
Weiss, K. A. Rauen.
1275
W Assessment of Individuals with
BRCA1
and
BRCA2
large genomic rearrangements in high-risk
breast cancer and ovarian cancer families.
L. Zhang, A.
Arnold, M. Harlan, M. Robson.
1276
T Genetic background of familial colorectal
cancer type X.
T. T. Nieminen, J.-P. Mecklin, H. J.
Järvinen, P. Peltomäki.
1277
F Development of a robust method for
establishing B cell lines using Epstein-Barr virus.
I.
Danjoh, R. Shirota, Y. Nakamura.
1278
W Association of single nucleotide
polymorphisms in ER
a
,
ER
b
,
CYP17A1 and CYP19A1
with breast cancer risk: A case control study from
North India.
S. Chattopadhyay, S. V. S. Deo, N. K.
Shukla, S. A. Husain.
1279
T Efficacy of Sequenom Sample ID Plus®
SNP genotyping in identification of FFPE tumor
samples.
J. K. Miller, N. Buchner, D. Pasternack, J. D.
McPherson.
Statistical Genetics and Genetic
Epidemiology
1280
W Gene-specific accelerated transcriptional
1256
F Exome and whole genome mutational landscape
in pancreatic ductal adenocarcinoma.
L. Timms, A.
Panchal, L. Mullen, J. Johns, R. Denroche, R. De Borja,
F. Yousif, Z. Zha, M. Sam, A. M. K. Brown, T. Beck, J. D.
McPherson.
1257
W De novo germline mosaic
BRCA1
exon deletion
associated with bilateral breast cancer.
M. Tischkowitz,
I. Delon, A. Taylor, A. Molenda, J. Drummond, K. Oakhill,
A. Girling, H. Liu, J. Whittaker, R. Treacy.
1258
T Single-nucleotide variant calling from low-
coverage single-cell sequence data using tumor
population structure.
S. Vattathil, N. Navin, P. Scheet.
1259
F Initial genomic analysis of a pure erythroid
leukemia developing in association with hydroxyurea
treatment for sickle cell anemia.
Z. Wang, D. Darbari, Z.
McIver, I. Maric, L. Diaw, Y. Song, P. Johansson, J. B. He,
J. Wei, A. J. Barrett, J. Khan, J. G. Taylor.
1260
W Novel L1 and Alu retrotransposon insertions
in cancer-related gene loci in the NCI-60 cancer cell
lines.
J. Zampella, K. Burns.
1261
T Exome sequencing approach for identification
of causative mutations in neurofibromatosis type
1-
associated plexiform neurofibromas.
A. Pemov,
H. Li, M. Wallace, D. R. Stewart, NISC Comparative
Sequencing Program, NHGRI, NIH Intramural Sequencing
Center.
1262
F
DICER1
RNAseIIIb domain is mutated at two
different sites in two different lesions in the same
patient.
M. Wu, N. Sabbaghian, N. Hamel, C. Choong, A.
Charles, W. Foulkes.
1263
W Multiplex PCR-based targeted deep
sequencing of the comprehensive human lung cancer
gene panel for the detection of
KRAS
and
EGFR
mutations.
Q. Peng, R. Gardner, N. Slepushkina, V.
Devgan.
1264
T Highly sensitive detection of rare somatic
mutations in tissue and plasma.
A. Marziali.
1265
F Integrative investigation on breast cancer by
ER, PR and HE2-defined subgroups using mRNA
and microRNA expression profiling and cancer
core pathway analysis.
X. Dai, S. Khan, T. Heikkinen,
P. Heikkilä, K. Aittomäki, C. Blomqvist, D. Greco, H.
Nevanlinna.
1266
W Novel oligoheterocycles and potential ability as
anti-cancer therapy.
S. Al-Aqeel.
1267
T Relative telomere length differs according
to DNA extraction method.
L. Boardman, K.
Litzelman, R. Johnson, M. Devine, R. Firl, A. Johnson,
M. Vincent, J. Cunningham, C. Engelman, S. Seo,
R. Gangnon, D. Rider, G. Petersen, S. Thibodeau, H.
Skinner.
1268
F Hereditary breast/ovarian cancer in Algerian
population: Molecular analysis of
BRCA1
and
BRCA2